Patrick M Boland
7PUBLICATIONS
45CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 31, 2025
Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer.Robert W Lentz, Julie Lang, Todd M Pitts
|Aug 29, 2025
Proto-Oncogene HRAS Transcript Level and Overall Survival in Stages II and III Colorectal Cancer.Donghyun Kim, Saima Sharif, Juan Antonio Raygoza Garay
|Dec 26, 2024
A Phase 1b study of the OxPhos inhibitor ME-344 with bevacizumab in refractory metastatic colorectal cancer.Patrick M Boland, Heinz-Josef Lenz, Kristen K Ciombor
|May 02, 2024
A phase I/II study of nintedanib and capecitabine for refractory metastatic colorectal cancer.Patrick M Boland, John M L Ebos, Kristopher Attwood
|Oct 14, 2021
Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer.Christos Fountzilas, David L Bajor, Sarbajit Mukherjee
Pageof 2
Frequent Collaborators
1 joint publications
Christos Fountzilas
1 joint publications
David L Bajor
1 joint publications
Joel Saltzman
1 joint publications
Hanna R Rosenheck
1 joint publications
Erik S Knudsen
1 joint publications
Jason B Muhitch
1 joint publications
Scott I Abrams
1 joint publications
Alan D Hutson
1 joint publications
Pawel Kalinski
1 joint publications
Marwan Fakih
